All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Salmonella outbreak linked to moringa supplements reaches 119 cases across 36 states; investigation reopened

By

Joseph James

6d ago· 7 min readenNews

Summary

A Salmonella outbreak linked to moringa leaf powder supplements has expanded to 119 confirmed cases across 36 states, with 32 hospitalizations and no deaths. Initially declared over in March 2026, the investigation was reopened in May after 22 new illnesses emerged. The CDC estimates the true case count is likely much higher, with approximately 29 undetected cases for every confirmed one. A parallel investigation has also linked MOGO-brand moringa capsules to an additional 18 illnesses. Multiple brands have been recalled, and officials are warning consumers to identify and avoid affected products.

Source

bskySalmonella outbreak linked to moringa supplements reaches 119 cases across 36 states; investigation reopenedmedicaldaily.com

Key quotes

· 4 pulled
A Salmonella outbreak linked to moringa leaf powder supplements was declared over in March 2026. It is no longer over.
As of May 27, 2026, the CDC and FDA have confirmed 119 people infected across 36 states, with 32 hospitalizations and no deaths.
The CDC estimates that for every confirmed Salmonella case, approximately 29 go undetected.
A separate, parallel investigation has linked MOGO-brand moringa capsules to an additional 18 illnesses.
Snippet from the RSS feed
A Salmonella outbreak linked to moringa leaf supplements has reached 119 cases in 36 states. Multiple brands recalled. Here's how to identify affected products and what to do.

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.